Drug
Oratopo
Oratopo: highest development phase Phase 1, developed by Athenex. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Athenex
Trials
| Drug | Phase | Indication |
|---|---|---|
| Oratopo NCT03987685 | Phase 1 | Solid Tumor |
Latest
No recent events.
Follow Oratopo on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.